Early Vascular Response of a Biodegradable Polymer‐Coated Sirolimus‐Eluting Stent in Patients With ST‐Segment Elevation Myocardial Infarction—The OCIMI Study
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70046 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2025. Written by Atul Abhyankar and 8 co-authors. Institution: Shri B D Mehta Mahavir Heart Institute, Surat, India. Major MEDLINE topics: Drug-Eluting Stents, Sirolimus, ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention. Cited 1 times so far (Crossref); 33 references. Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
Few studies have addressed the early healing pattern of ultrathin strut drug‐eluting stents implanted specifically for the treatment of acute myocardial infarction. AIMS This study employed optical coherence tomography (OCT) to assess neointimal coverage and vascular healing following implantation of ultrathin biodegradable polymer‐coated sirolimus‐eluting stents (SES) in patients with ST‐segment elevation myocardial infarction (STEMI).
Methods
The OCIMI study was a prospective, single‐center investigation of 23 STEMI patients treated with Supraflex Cruz SES (Sahajanand Medical Technologies Ltd., Surat, India) during primary PCI between September 2019 and June 2020. All patients underwent OCT imaging at 3‐month follow‐up, and images were analyzed at an independent core laboratory by analysts blinded to clinical and procedural data.
Results
At the 3‐month follow‐up, no clinical events were reported. The analyzed stent length was 28.4 ± 12.0 mm, with a stent diameter of 2.70 ± 0.46 mm and a reference lumen diameter of 2.46 ± 0.44 mm. OCT demonstrated nearly complete stent strut coverage (99.94%), with uncovered struts observed in 0.06 ± 0.16% of total struts per stent. Incomplete stent apposition was present in 0.14 ± 0.37% of struts. The mean neointimal hyperplasia (NIH) area and thickness were 0.81 ± 0.40 mm 2 and 110 ± 40 µm, respectively, with a mean NIH unevenness score of 1.74 ± 0.19.
Conclusion
Primary PCI performed with Supraflex Cruz SES demonstrated excellent early vascular healing at the 3‐month OCT follow‐up. The extremely low incidence of uncovered struts may have implications for abbreviated dual antiplatelet therapy in high‐bleeding risk STEMI patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Shri B D Mehta Mahavir Heart Institute, Surat, India.
- Stanford University, Stanford, California, USA.
- Sahajanand Medical Technologies Limited, Surat, India.
ORCID profiles: Atul Abhyankar, Yamunesh Patel
Funding
- The authors received no specific funding for this work.
Cite
APA
Abhyankar, A., Patel, B., Jain, A., Patel, V., Patel, Y., Saito, K., Yoshida, A., Honda, Y., & Sudhir, K. (2025). Early Vascular Response of a Biodegradable Polymer‐Coated Sirolimus‐Eluting Stent in Patients With ST‐Segment Elevation Myocardial Infarction—The OCIMI Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70046
Vancouver
Abhyankar A, Patel B, Jain A, Patel V, Patel Y, Saito K, et al. Early Vascular Response of a Biodegradable Polymer‐Coated Sirolimus‐Eluting Stent in Patients With ST‐Segment Elevation Myocardial Infarction—The OCIMI Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70046
BibTeX
@article{Abhyankar2025,
author = {Abhyankar, Atul and Patel, Bhargav and Jain, Ankit and Patel, Vikas and Patel, Yamunesh and Saito, Kan and Yoshida, Akihiro and Honda, Yasuhiro and Sudhir, Krishnankutty},
title = {Early Vascular Response of a Biodegradable Polymer‐Coated Sirolimus‐Eluting Stent in Patients With ST‐Segment Elevation Myocardial Infarction—The OCIMI Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70046}
}
EUVIMED